Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial

BACKGROUND: Human papillomavirus (HPV) vaccines are given as a two-dose schedule in children aged 9–14 years, or as three doses in older individuals. We compared antibody responses after one dose of HPV vaccine in the Dose Reduction Immunobridging and Safety Study (DoRIS), a randomised trial of diff...

Descripción completa

Detalles Bibliográficos
Autores principales: Baisley, Kathy, Kemp, Troy J, Kreimer, Aimée R, Basu, Partha, Changalucha, John, Hildesheim, Allan, Porras, Carolina, Whitworth, Hilary, Herrero, Rolando, Lacey, Charles J, Schiller, John T, Lucas, Eric, Mutani, Paul, Dillner, Joakim, Indangasi, Jackton, Muwonge, Richard, Hayes, Richard J, Pinto, Ligia A, Watson-Jones, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638025/
https://www.ncbi.nlm.nih.gov/pubmed/36113532
http://dx.doi.org/10.1016/S2214-109X(22)00306-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638025/
https://www.ncbi.nlm.nih.gov/pubmed/36113532
http://dx.doi.org/10.1016/S2214-109X(22)00306-0

Ejemplares similares